ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1522	National Cancer Institute	Html	en	Childhood Brain Stem Glioma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood brain stem glioma.	PDQ Childhood Brain 0.262624 cancer treatment 0.317391 new cancer cells 0.250632 brain stem glioma 0.990842 metastatic brain tumors 0.262145 type 0.250835 PDQ cancer information 0.305049 clinical trial search 0.257718 brain tumors 0.389165 children 0.259907 clinical trials 0.541127 health care providers 0.255221 Pediatric Treatment Editorial 0.256101 cancer information summary 0.282392 clinical trial 0.361183 patients 0.252235 NCI PDQ cancer 0.25809 radiation therapy 0.3037 Treatment Editorial Board 0.258484 intrinsic pontine glioma 0.314731 focal childhood brain 0.250848 late effects 0.256779 treatment 0.494086 focal glioma 0.286058 cancer cells 0.359639	brain stem gliomas 0.410944 primary brain tumors 0.262357 PDQ Pediatric Treatment 0.253085 signs 0.25352 Benign brain tumors 0.261631 treatment clinical trials 0.275821 National Cancer Institute 0.282821 following PDQ treatment 0.270231 effects cancer treatment 0.263814 new treatment 0.290537 childhood cancer information 0.253956 childhood brain tumors 0.305915 BRAF kinase 0.259925 treatment clinical trial 0.25851 PDQ summary 0.250138 Malignant brain tumors 0.261555 cancer clinical trials 0.275926 focal brain stem 0.331856 treatment options 0.261824 brain tissue 0.259205 cancer 0.498153 standard treatment 0.287654 BRAF kinase inhibitor 0.253173 childhood brain stem 0.659927	CLICK HERE
1545	National Cancer Institute	Html	en	Adult Hodgkin Lymphoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult Hodgkin lymphoma.	red blood cells 0.404993 cancer treatment 0.406441 body 0.406679 PDQ cancer information 0.415705 unfavorable Hodgkin lymphoma 0.403766 Non-Hodgkin Lymphoma Treatment 0.396504 clinical trial search 0.387461 pregnant women 0.365816 favorable Hodgkin lymphoma 0.403909 white blood cells 0.390827 favorable adult Hodgkin 0.379079 unfavorable adult Hodgkin 0.379392 clinical trials 0.634552 lymph nodes 0.463894 cancer information summary 0.39389 clinical trial 0.489293 stem cell transplant 0.415484 recurrent Hodgkin lymphoma 0.402776 adult hodgkin lymphoma 0.802336 patients 0.379207 blood cells 0.446195 weight loss 0.391968 NCI PDQ cancer 0.365284 radiation therapy 0.587067 Nodular sclerosing Hodgkin 0.384149	lymph node groups 0.460532 treatment 0.56475 night sweats 0.39371 Hodgkin Lymphoma Treatment 0.422215 cancer cells 0.401875 cellularity Hodgkin lymphoma 0.419706 swollen lymph nodes 0.429808 treatment clinical trials 0.386111 National Cancer Institute 0.39221 lymph vessels 0.383555 new treatment 0.393163 advanced hodgkin lymphoma 0.435901 Hodgkin lymphomas 0.368401 classical Hodgkin lymphoma 0.419308 bone marrow 0.427904 depletion Hodgkin lymphoma 0.419209 sedimentation rate 0.371778 hodgkin lymphoma 0.94955 cancer clinical trials 0.401646 stage 0.410094 Combination chemotherapy 0.415703 cancer 0.682215 information 0.416232 appropriate cancer treatment 0.37213	CLICK HERE
1600	National Cancer Institute	Html	en	Nutrition in Cancer Care (PDQ®)–Patient Version	Expert-reviewed information summary about the causes and management of nutritional problems that occur in patients with cancer.	cancer treatment 0.815724 foods 0.591336 body 0.50774 PDQ cancer information 0.539768 general health 0.483553 mouth sores 0.564301 nutrition problems 0.511061 cancer information summary 0.514016 Cancer Care section 0.490312 enteral nutrition 0.493173 cancer care 0.499373 cancer patients 0.772982 weight loss 0.581589 dry mouth 0.559356 NCI PDQ cancer 0.489458 nutrition 0.675709 effects 0.559624 good nutrition 0.476052 nutrition therapy 0.671346 radiation therapy 0.583611 Advanced Cancer section 0.512145 nutrition support care 0.489001 cancer treatments 0.531014 parenteral nutrition support 0.491942 cancer prevention 0.486895	cancer cells 0.480334 Cancer Information Service 0.511605 palliative care 0.476957 nutrients 0.514961 certain foods 0.495203 parenteral nutrition 0.492581 National Cancer Institute 0.539267 advanced cancer 0.530168 white blood cell 0.522179 fight infection 0.479873 low white blood 0.494372 breast cancer 0.518198 cancer patients control 0.508745 health 0.485589 food 0.567108 PDQ summary 0.508916 Eat foods 0.503278 following nutrition problems 0.482655 mouth 0.591038 cancer information summaries 0.483904 comprehensive cancer information 0.47883 cancer 0.980934 information 0.558957 Cancer survivors 0.484253	CLICK HERE
1718	National Cancer Institute	Html	en	Pap and HPV Testing	A fact sheet that describes the Pap and HPV tests, possible results from those tests, and the link between HPV and cervical cancer.	Pap test results 0.318639 precancerous cervical lesions 0.292159 squamous cells 0.289348 high-risk HPV 0.671741 First-line HPV testing 0.290741 squamous cell abnormalities 0.296427 primary HPV screening 0.318981 cervical screening 0.408649 glandular cell abnormalities 0.323902 professional cervical cancer 0.287037 cervical cells 0.449089 Pap test 0.978312 HPV testing 0.403472 frequent cervical screening 0.280097 cell abnormalities 0.445026 HPV test 0.442688 negative HPV test 0.307642 cervical cancer screening 0.819575 positive HPV test 0.337496 cervical cancer 0.958343 HPV DNA test 0.30151 Pap cytology test 0.279358 early cervical cancers 0.308324 HPV infections 0.362202	HPV test results 0.327074 abnormal cells 0.314778 abnormal cervical cells 0.343301 precancerous cervical lesion 0.309268 HPV 0.765136 Pap test result 0.433853 different HPV tests 0.296834 cervical cell abnormalities 0.361261 cobas HPV test 0.304363 high-risk HPV types 0.661339 additional high-risk HPV 0.303577 new cervical cancers 0.27692 high-risk HPV type 0.405337 cervical cancer risk 0.324311 HPV cotesting 0.335213 liquid-based Pap cytology 0.286767 future cervical cancer 0.287194 abnormal Pap test 0.300522 HPV infection 0.371378 cells 0.464647 regular cervical screening 0.330087 Routine cervical screening 0.314661 Pap testing 0.293059 cell changes 0.293167	CLICK HERE
1935	National Cancer Institute	Html	es	Tratamiento del ependimoma infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del ependimoma infantil.	radiocirugía estereotáctica 0.685192 siguientes procedimientos 0.332065 efectos secundarios meses 0.562136 siguientes áreas 0.378745 huesos dorsales 0.375848 general recidiva 0.34956 efectos tardíos 0.729968 PDQ Efectos tardíos 0.453185 cabo irm 0.352274 líquido cefalorraquídeo 0.982409 punción espinal.Ampliar 0.373407 estudio clínico 0.337757 National Cancer Institute 0.329628	siguientes riesgos 0.321782 Instituto Nacional 0.357335 PDQ Tratamiento 0.392525 determinados cambios 0.326515 gen rela 0.670707 nuevos tipos 0.348217 siguientes factores 0.370167 sistema nervioso central 0.663463 Physician Data Query 0.423559 segura.ampliar craneotomía 0.353248 cuánto tumor 0.478632 siguientes sumarios 0.438618	CLICK HERE
1945	National Cancer Institute	Html	es	Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de los problemas de salud que aparecen una vez que termina el tratamiento del cáncer.	cancer statistics 0.312893 among adult survivors 0.309342 health insurance 0.30576 childhood leukemia survivors 0.314627 Marrow Transplant Survivor 0.306695 largo plazo 0.353459 Cancer Survivor cohort 0.310798 CA Cancer 0.308516 group long-term follow-up 0.307764 mortality among 5-year 0.309974 health conditions 0.3067 young adult cancers 0.387348 late mortality 0.309117 Ness KK 0.312945 among childhood cancer 0.329959 adult survivors 0.341543 Hudson MM 0.322937 among survivors 0.313213 British Childhood Cancer 0.315849 utilization among long-term 0.306183 childhood cancer 0.973475 cancer survivor study 0.608871 late effects 0.312383 SEER Cancer Statistics 0.308306 long-term survivors 0.338777	health care utilization 0.307102 Survivor Study cohort 0.310239 chronic health conditions 0.305835 among adolescent survivors 0.308292 Care Cancer 0.309376 among 5-year survivors 0.328567 Pediatr Blood Cancer 0.42011 oncology group long-term 0.310223 adolescent cancers 0.313982 efectos tardíos 0.375703 survivors research program 0.306998 report from 0.396085 National Cancer Institute 0.308232 Oeffinger KC 0.306859 health care 0.314251 mortality among survivors 0.308816 Clin Oncol 0.375569 childhood cancer survivor 0.872407 medical care 0.307228 among long-term survivors 0.315379 late mortality among 0.306982 long-term follow-up guidelines 0.320022 Outcomes Among Childhood 0.309917 children's oncology group 0.433388	CLICK HERE
3576	National Cancer Institute	Html	en	Cancer Prevention Research	NCI’s prevention research has a broad focus, from identifying environmental and lifestyle factors that influence cancer risk to studying the biology of how cancer develops and studying ways to disseminate prevention interventions.	potential preventive therapies 0.441911 cancer prevention trials 0.552513 Drug Development Program 0.440287 PREVENT Cancer Preclinical 0.524374 higher cancer rates 0.5328 public health imperative 0.449962 Tobacco Control Research 0.447635 tobacco control programs 0.463087 invasive cancer 0.460548 specific population groups 0.436493 behavioral risk factors 0.665388 cancer care 0.47747 NCI’s Division 0.485356 cervical cancer 0.456337 Reduce Cancer Health 0.518587 FDA-approved HPV vaccines—work 0.439068 NCI’s Center 0.488421 Cancer Epidemiology 0.455548 prevention-focused clinical studies 0.444916 cancer health disparities 0.673431 Cancer Control 0.456877 risk reduction 0.469434 cancer screening 0.48636 cancer prevention 0.875489	United States 0.669252 new cancer prevention 0.553181 annual cancer-related deaths 0.450355 Cancer Research 0.477162 studies 0.468685 HPV-associated cancer 0.458082 cancer researchers 0.479223 substantially increased risk 0.487266 prevention research efforts 0.4695 HPV vaccine trials 0.440028 NCI Community Oncology 0.488471 new preventive therapy 0.454621 cancer development 0.485138 people 0.446203 cancer prevention research 0.671334 cancer disparities 0.497724 physical activity 0.439301 bivalent HPV vaccine 0.436545 Cancer Prevention Clinical 0.54727 NCI Cohort Consortium 0.479534 cancer risk 0.971388 cancer 0.983944 cancer incidence 0.537166 genome-wide association studies 0.438797	CLICK HERE
3876	National Cancer Institute	Html	en	The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)	Apply for the NCI F99/K00 Award that helps late-stage doctoral candidates finish their training and then transition into cancer-focused research positions.	K00 phase institution 0.388613 applicant institution 0.265884 Research Doctoral candidates 0.275389 Funding Opportunity Announcement 0.903132 research supplies 0.244496 Career Development Award 0.350987 k00 award 0.331719 Ph.D. dissertation requirements 0.237088 phase institutional representative 0.335728 project award period 0.253621 indirect costs 0.425626 NCI F99/K00 Predoc 0.307817 Institutional Allowance 0.281782 Career Development Support 0.249362 Research Career Development 0.347168 k00 phase 0.762118 Research Plan section 0.261319 career development skills 0.241364 health-related Ph.D. program 0.243519 F99 primary sponsor 0.23706 Research Service Award 0.312163 Individual Research Career 0.265006 mandatory NCI-sponsored conference 0.307767 Opportunity Announcement instructions 0.260896 career development research 0.317687	dissertation research project 0.396866 Ph.D. degree program 0.256222 valid U.S. visas 0.237157 Postdoctoral Fellow Transition 0.248842 Application Guide 0.311615 NCI Predoctoral 0.237727 F99 phase 0.471921 dissertation research training 0.299174 program staff 0.238571 Program Staff Contact 0.236142 Research Strategy 0.247855 F99/K00 Award 0.359733 F99 grant mechanism 0.235643 assigned NCI Program 0.270275 Development Award Supplemental 0.254853 F99 award 0.269956 fringe benefits 0.272186 valid U.S. visa 0.254123 career development 0.562023 Research Plan Sections 0.252481 Fellowship Applicant Section 0.257658 F99/K00 Award application 0.300758 health-related research field 0.279872 Postdoctoral Research Direction 0.273719	CLICK HERE
15846	National Cancer Institute	Html	en	RAS Biochemistry and Biophysics	This RAS Biochemistry and Biophysics lab investigates signaling by RAS proteins, which is regulated by the interactions with substrates, protein partners, and membranes.	cell membranes 0.473685 Nuclear Magnetic Resonance 0.585708 Biophysics Group team 0.636374 mutant RAS 0.650163 KRAS proteins 0.677168 nanodiscs 0.374828 cancer deaths 0.469996 fully modified KRAS 0.804703 different cancers 0.503399 Washington University 0.469252 analytical ultracentrifugation 0.487353 protein-nanodisc complexes 0.475228 atomic levels 0.48075 stephena@mail.nih.gov 0.45777 Ridge National Laboratory 0.591017 Rodolfo Ghirlando 0.472711 artificial lipid bilayers 0.682865 KRAS4b protein 0.638588 sensitive techniques 0.481762 Carla Mattos 0.458864 California 0.350663 Northeastern University 0.475122 RAS proteins 0.703869 neutron scattering 0.468073 RAS Biochemistry 0.737959	different KRAS 0.64483 different lipid compositions 0.713219 Chris Stanley 0.450409 fully modified KRAS4b 0.914598 Jay Groves 0.463932 interactions 0.440981 intrinsic hydrolysis rates 0.625326 numerous interacting partner 0.64654 inner plasma membrane 0.635847 Marco Tonelli 0.478206 surrogate 0.33572 St. Louis 0.448878 Digestive Kidney Dieases 0.603479 National Institute 0.589812 Paul Henderson 0.462542 single molecule analysis 0.605131 different mutant proteins 0.699255 dozen different mutants 0.686498 biophysical assays 0.484191 binding affinities 0.477155 Steve Sligar 0.461855 biophysics group 0.812528 major oncogenic mutants 0.687098 KRAS account 0.631848	CLICK HERE
15877	National Cancer Institute	Html	es	Antineoplastones (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre los antineoplastones como tratamiento para personas con cáncer.	corta duración 0.52325 suficientes antineoplastones 0.570315 Centro Nacional 0.534282 New Hampshire Avenue 0.523956 cabo ensayos 0.607081 Drug Administration 0.514884 antineoplastones a10 0.621411 NCI Best Case 0.546794 siguientes tipos 0.528576 PDQ Antineoplastones 0.580269 datos bibliográficos pubmed 0.525907 siguientes preguntas 0.515649 fase ii 0.701787 células tumorales animales 0.553458 National Cancer Institute 0.529942 siguientes riesgos 0.520138 seguro médico 0.513988	Instituto Nacional 0.710175 Salud Complementaria 0.553301 Visuals Online 0.517781 complementarias revisa 0.52541 Physician Data Query 0.604461 antineoplastones a2 0.575169 Estados Unidos 0.855832 corto plazo 0.520833 libre uso 0.517405 página manejo 0.516526 ¿El tratamiento 0.536286 Clínica Mayo 0.524069 ¿Los beneficios 0.515122 juntos cam 0.514422 Series Program 0.514906 medicina complementaria 0.99587	CLICK HERE